Skip to main content

Advertisement

Log in

Cunninghamella bertholletiae Infection in a HLA-Haploidentical Hematopoietic Stem Cell Transplant Recipient with Graft Failure: Case Report and Review of the Literature

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Cunninghamella bertholletiae as a rare cause of mucormycosis has been described almost exclusively in immunosuppressed patients such as hematopoietic stem cell transplant (HSCT) recipients. The infection is associated with high rates of mortality despite aggressive treatment. We describe a 40-year-old male with HLA-haploidentical HSCT developed fungal pneumonitis caused by C. bertholletiae complicated by graft failure and prolonged neutropenia. The patient died 102 days after HSCT despite early use of posaconazole and amphotericin B, which are believed to be the two most effective antifungal antibiotics against C. bertholletiae. The case highlights extreme unfavorable outcome in C. bertholletiae infection and neutropenia as a major risk factor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Wingard JR. The changing face of invasive fungal infections in hematopoietic cell transplant recipients. Curr Opin Oncol. 2005;17(2):89–92.

    Article  PubMed  Google Scholar 

  2. Garcia-Vidal C, Upton A, Kirby KA, Marr KA. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis. 2008;47(8):1041–50.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Gomes MZ, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev. 2011;24(2):411–45.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Luo Y, Xiao H, Lai X, et al. T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT. Blood. 2014;124(17):2735–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE, Network E. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother. 2003;51(1):45–52.

    Article  CAS  PubMed  Google Scholar 

  6. Sabatelli F, Patel R, Mann PA, et al. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother. 2006;50(6):2009–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Darrisaw L, Hanson G, Vesole DH, Kehl SC. Cunninghamella infection post bone marrow transplant: case report and review of the literature. Bone Marrow Transplant. 2000;25(11):1213–6.

    Article  CAS  PubMed  Google Scholar 

  8. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clin Infect Dis. 2008;46(12):1813–21.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Garbino J, Myers C, Ambrosioni J, Gumy-Pause F. Report of a successful treatment of pulmonary Cunninghamella bertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature. J Pediatr Hematol Oncol. 2010;32(2):85–7.

    Article  PubMed  Google Scholar 

  10. Xhaard A, Lanternier F, Porcher R, et al. Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003–2008). Clin Microbiol Infect. 2012;18(10):E396–400.

    Article  CAS  PubMed  Google Scholar 

  11. Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis. 2005;191(8):1350–60.

    Article  PubMed  Google Scholar 

  12. Matsumoto K, Yamamoto W, Ohgusa E, et al. Disseminated Cunninghamella bertholletiae infection with septic pulmonary embolism after allogeneic bone marrow transplantation. Transpl Infect Dis. 2014;16(2):304–6.

    Article  CAS  PubMed  Google Scholar 

  13. Strasfeld L, Espinosa-Aguilar L, Gajewski JL, et al. Emergence of Cunninghamella as a pathogenic invasive mold infection in allogeneic transplant recipients. Clin Lymphoma Myeloma Leuk. 2013;13(5):622–8.

    Article  PubMed  Google Scholar 

  14. Kimura M, Araoka H, Uchida N, et al. Cunninghamella bertholletiae pneumonia showing a reversed halo sign on chest computed tomography scan following cord blood transplantation. Med Mycol. 2012;50(4):412–6.

    Article  PubMed  Google Scholar 

  15. Righi E, Giacomazzi CG, Lindstrom V, et al. A case of Cunninghamella bertholettiae rhino-cerebral infection in a leukaemic patient and review of recent published studies. Mycopathologia. 2008;165(6):407–10.

    Article  CAS  PubMed  Google Scholar 

  16. Sivakumar S, Mathews MS, George B. Cunninghamella pneumonia in postbone marrow transplant patient: first case report from India. Mycoses. 2005;48(5):360–2.

    Article  CAS  PubMed  Google Scholar 

  17. Garey KW, Pendland SL, Huynh VT, Bunch TH, Jensen GM, Pursell KJ. Cunninghamella bertholletiae infection in a bone marrow transplant patient: amphotericin lung penetration, MIC determinations, and review of the literature. Pharmacotherapy. 2001;21(7):855–60.

    Article  CAS  PubMed  Google Scholar 

  18. Carceller F, Oñoro G, Buitrago MJ, et al. Cunninghamella bertholletiae infection in children: review and report of 2 cases with disseminated infection. J Pediatr Hematol Oncol. 2014;36(2):e109–14.

    Article  PubMed  Google Scholar 

  19. Simitsopoulou M, Georgiadou E, Walsh TJ, Roilides E. Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp. Med Mycol. 2010;48(5):720–4.

    Article  CAS  PubMed  Google Scholar 

  20. Petraitis V, Petraitiene R, Antachopoulos C, et al. Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism. Med Mycol. 2013;51(1):72–82.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was jointly supported by Grants from Zhejiang Provincial Natural Science Foundation of China (LY14H080002, Y2110183), the National Natural Science Foundation of China (81470341, 81500157), Zhejiang Medical Technology and Education (201476288, 2014KYA066) and Jinhua Administration of Science and Technology (2014-3-006).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to He Huang.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Additional information

Chao Luo and Jiasheng Wang have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luo, C., Wang, J., Hu, Y. et al. Cunninghamella bertholletiae Infection in a HLA-Haploidentical Hematopoietic Stem Cell Transplant Recipient with Graft Failure: Case Report and Review of the Literature. Mycopathologia 181, 753–758 (2016). https://doi.org/10.1007/s11046-016-0030-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-016-0030-7

Keywords

Navigation